
RECURRENT EPISODES OF FEVER AND ARTHRITIS IN AN ADULT PATIENT
Author(s) -
Claudia Cobilinschi,
Daniela Opris Belinski,
Denisa Predeţeanu,
Ruxandra Ionescu,
Bucharest Pharmacy
Publication year - 2017
Publication title -
romanian journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 2069-6086
pISSN - 1843-0791
DOI - 10.37897/rjr.2017.2.8
Subject(s) - familial mediterranean fever , mefv , medicine , colchicine , amyloidosis , arthritis , pyrin domain , complication , dermatology , gene mutation , mutation , gene , disease , inflammation , genetics , inflammasome , biology
Familial Mediterranean Fever (FMF) is the most common condition in the group of autoinflammatory diseases. It has a relatively heterogeneous clinical display included in the Tel-Hashomer diagnostic criteria that can be further confirmed by genetic testing showing a mutation in the MEFV gene. AA Amyloidosis is the most sever complication in these patients. Colchicine is the standard treatment and/or alternative biological agents if necessary. This article aims to describe the evolution of a patient with FMF, firstly diagnosed as reactive arthritis, his clinical manifestations and therapeutic options.